{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:17:42Z","timestamp":1769905062625,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00508-013-0402-7","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T06:59:05Z","timestamp":1375340345000},"page":"481-486","source":"Crossref","is-referenced-by-count":23,"title":["Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study","Radiochemotherapie mit Temozolomid f\u00fcr Patienten mit Hirnmetastasen bei nicht kleinzelligem Lungenkarzinom"],"prefix":"10.1007","volume":"125","author":[{"given":"Marco Ronald","family":"Hassler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Hendrik","family":"Knocke-Abulesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Altorjai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Marosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,2]]},"reference":[{"issue":"3","key":"402_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1012226718323","volume":"53","author":"LE Abrey","year":"2001","unstructured":"Abrey LE, et al. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol. 2001;53(3):259\u201365.","journal-title":"J Neurooncol"},{"issue":"9","key":"402_CR2","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/cncr.23859","volume":"113","author":"R Addeo","year":"2008","unstructured":"Addeo R, et al. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for non-small cell lung cancer and breast cancer patients with brain metastases. Cancer. 2008;113(9):2524\u201331.","journal-title":"Cancer"},{"issue":"4","key":"402_CR3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3816\/CLC.2002.n.009","volume":"3","author":"CS Adonizio","year":"2002","unstructured":"Adonizio CS, et al. Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patients. Clin Lung Cancer. 2002;3(4):254\u20138.","journal-title":"Clin Lung Cancer"},{"issue":"17","key":"402_CR4","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2002.04.140","volume":"20","author":"D Antonadou","year":"2002","unstructured":"Antonadou D, et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol. 2002;20(17):3644\u201350.","journal-title":"J Clin Oncol"},{"issue":"10","key":"402_CR5","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2005.00.331","volume":"23","author":"H Athanassiou","year":"2005","unstructured":"Athanassiou H, et al. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol. 2005;23(10):2372\u20137.","journal-title":"J Clin Oncol"},{"issue":"3","key":"402_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1556-0864(15)31575-6","volume":"1","author":"NW Choong","year":"2006","unstructured":"Choong NW, et al. Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006;1(3):245\u201351.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"402_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-004-9176-0","volume":"71","author":"C Christodoulou","year":"2005","unstructured":"Christodoulou C, et al. Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study. J Neurooncol. 2005;71(1):61\u20135.","journal-title":"J Neurooncol"},{"issue":"9","key":"402_CR8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/annonc\/mdl146","volume":"17","author":"AB Cortot","year":"2006","unstructured":"Cortot AB, et al. Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study. Ann Oncol. 2006;17(9):1412\u20137.","journal-title":"Ann Oncol"},{"issue":"9","key":"402_CR9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0959-8049(03)00234-X","volume":"39","author":"R Dziadziuszko","year":"2003","unstructured":"Dziadziuszko R, et al. Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Eur J Cancer. 2003;39(9):1271\u20136.","journal-title":"Eur J Cancer"},{"issue":"2","key":"402_CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000192586","volume":"76","author":"C Kouroussis","year":"2009","unstructured":"Kouroussis C, et al. Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study. Oncology. 2009;76(2):112\u20137.","journal-title":"Oncology"},{"issue":"7","key":"402_CR11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000102557","volume":"30","author":"JR Kouvaris","year":"2007","unstructured":"Kouvaris JR, et al. Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie. 2007;30(7):361\u20136.","journal-title":"Onkologie"},{"issue":"3","key":"402_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-005-9095-8","volume":"78","author":"AM Omuro","year":"2006","unstructured":"Omuro AM, et al. Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial. J Neurooncol. 2006;78(3):277\u201380.","journal-title":"J Neurooncol"},{"issue":"1","key":"402_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijrobp.2004.04.061","volume":"61","author":"E Verger","year":"2005","unstructured":"Verger E, et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys. 2005;61(1):185\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"402_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/14737140.2.5.495","volume":"2","author":"HB Newton","year":"2002","unstructured":"Newton HB. Chemotherapy for the treatment of metastatic brain tumors. Expert Rev Anticancer Ther. 2002;2(5):495\u2013506.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"402_CR15","first-page":"998","volume":"6","author":"DS Middlemas","year":"2000","unstructured":"Middlemas DS, et al. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. Clin Cancer Res. 2000;6(3):998\u20131007.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"402_CR16","first-page":"1769","volume":"3","author":"E Raymond","year":"1997","unstructured":"Raymond E, et al. Activity of temozolomide against human tumor colony-forming units. Clin Cancer Res. 1997;3(10):1769\u201374.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"402_CR17","first-page":"1398","volume":"7","author":"KS Srivenugopal","year":"2001","unstructured":"Srivenugopal KS, et al. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. Clin Cancer Res. 2001;7(5):1398\u2013409.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"402_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.cmr.0000136711.75287.55","volume":"14","author":"R Ridolfi","year":"2004","unstructured":"Ridolfi R, et al. Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup. Melanoma Res. 2004;14(4):295\u20139.","journal-title":"Melanoma Res"},{"key":"402_CR19","doi-asserted-by":"crossref","unstructured":"Giorgio CG, et al. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study. Lung cancer. 2005;50(2):247\u201354.","DOI":"10.1016\/j.lungcan.2005.05.026"},{"issue":"1","key":"402_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1634\/theoncologist.8-1-69","volume":"8","author":"BL Ebert","year":"2003","unstructured":"Ebert BL, et al. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer. Oncologist. 2003;8(1):69\u201375.","journal-title":"Oncologist"},{"issue":"1","key":"402_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11060-007-9491-3","volume":"87","author":"FM Iwamoto","year":"2008","unstructured":"Iwamoto FM, et al. A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol. 2008;87(1):85\u201390.","journal-title":"J Neurooncol"},{"issue":"6","key":"402_CR22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/cncr.22127","volume":"107","author":"E Rivera","year":"2006","unstructured":"Rivera E, et al. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer. 2006;107(6):1348\u201354.","journal-title":"Cancer"},{"issue":"1","key":"402_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijrobp.2009.04.026","volume":"75","author":"BL Carlson","year":"2009","unstructured":"Carlson BL, et al. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts. Int J Radiat Oncol Biol Phys. 2009;75(1):212\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"402_CR24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ijrobp.2007.07.2366","volume":"69","author":"KA van Nifterik","year":"2007","unstructured":"van Nifterik KA, et al. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines. Int J Radiat Oncol Biol Phys. 2007;69(4):1246\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"402_CR25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8(7):1277\u201380.","journal-title":"J Clin Oncol"},{"issue":"3","key":"402_CR26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176\u201381.","journal-title":"Semin Radiat Oncol"},{"key":"402_CR27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2407-7-18","volume":"7","author":"R Addeo","year":"2007","unstructured":"Addeo R, et al. Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer. 2007;7:18.","journal-title":"BMC Cancer"},{"issue":"4","key":"402_CR28","first-page":"231","volume":"1","author":"LE Abrey","year":"2003","unstructured":"Abrey LE, Mehta MP. Treatment of brain metastases: a short review of current therapies and the emerging role of temozolomide. Clin Adv Hematol Oncol. 2003;1(4):231\u20136.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"2","key":"402_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00115-007-2372-3","volume":"79","author":"M Weller","year":"2008","unstructured":"Weller M. Chemotherapy for brain tumors in adult patients. Nervenarzt. 2008;79(2):231\u201341.","journal-title":"Nervenarzt"},{"key":"402_CR30","doi-asserted-by":"crossref","unstructured":"Antonadou D, Coliarakis N, Paraskevaidis M, et al. A multiinstitutional trial comparing survival of patients with brain metastases from lung cancer treated with Temozolomide plus radiotherapy versus radiotherapy alone. Lung Cancer 2003;41 Suppl 2:42.","DOI":"10.1016\/S0169-5002(03)91725-9"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-013-0402-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0402-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T05:21:38Z","timestamp":1563600098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-013-0402-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1007\/s00508-013-0402-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}